參考文獻 |
1. Lonsdale, K. Human Stones. Science 1968, 159 (3820), 1199-1207.
2. Parmar, M. S. Kidney Stone. Br. Med. J. 2004, 328(7453),1420-1424
3. Herring, L. C. Observations on the Analysis of Ten Thousand Urinary Calculi. J. Urol. 1962, 88 (4), 545-562.
4. Finlayson, B.; Reid, F. The Expectation of Free and Fixed Particles in Urinary Stone Disease. Investig. Urol. 1978, 15(6), 442-448.
5. Al-Atar, U.; Bokov, A. A.; Marshall, D.; Teichman, J. M. H.; Gates, B. D.; Ye, Z. G.; Branda, N. R. Mechanism of Calcium Oxalate Monohydrate Kidney Stones Formation: Layered Spherulitic Growth. Chem. Mater. 2010, 22 (4), 1318-1329.
6. Will, E. J.; Bijvoet, O. L. M.; Blomen, L. J. M. J.; van der Linden, H. Growth Kinetics of Calcium Oxalate Monohydrate. I. Method and Validation. J. Cryst. Growth 1983, 64 (2), 297-305.
7. Blomen, L. J. M. J.; Will, E. J.; Bijvoet, O. L. M.; van der Linden, H. Growth Kinetics of Calcium Oxalate Monohydrate. II. The Variation of Seed Concentration. J. Cryst. Growth 1983, 64 (2), 306-315.
8. Bijvoet, O. L. M.; Blomen, L. J. M. J.; Will, E. J.; van der Linden, H. Growth Kinetics of Calcium Oxalate Monohydrate. III. Variation of Solution. J. Cryst. Growth 1983, 64 (2), 316-325.
9. El-Shall, H.; Jeon, J. H.; Abdel-Aal, E. A.; Khan, S.; Gower, L.; Rabinovich, Y. A Study of Primary Nucleation of Calcium Oxalate Monohydrate: I. Effect of Supersaturation. Cryst. Res. Technol. 2004, 39 (3), 214-221.
10. El-Shall, H.; Jeon, J. H.; Abdel-Aal, E. A.; Khan, S.; Gower, L.; Rabinovich, Y. A Study of Primary Nucleation of Calcium Oxalate Monohydrate: II. Effect of Urinary Species. Cryst. Res. Technol. 2004, 39 (3), 222-229.
11. Hacherl, J. M.; Paul, E. L.; Buettner, H. M. Investigation of Imaging-Jet Crystallization with a Calcium Oxalate Model System. AIChE Journal 2003, 49 (9), 2352-2362.
12. Kok, D. J.; Papapoulos, S. E.; Bijvoet, O. L. M. Crystal Agglomeration is a Major Element in Calcium Oxalate Urinary Stone Formation. Kidney Int. 1990, 37 (1), 51-56.
13. Kok, D. J.; Papapoulos, S. E.; Blomen, L. J. M. J.; Bijvoet, O. L. M. Modulation of Calcium Oxalate Monohydrate Crystallization Kinetics In Vitro. Kidney Int. 1988, 34 (3), 346-350.
14. Štulajterová, R.; Medvecký, Ľ. Effect of Calcium Ions on Transformation Brushite to Hydroxyapatite in Aqueous Solutions. Colloids and Surfaces A: Physicochem. Eng. Aspects 2008, 316 (1-3), 104-109.
15. Pak, C. Y. C.; Adams-Huet, B.; Poindexter, J. R.; Pearle, M. S.; Peterson, R. D.; Moe, O. W. Relative Effect of Urinary Calcium and Oxalate on Saturation of Calcium Oxalate. Kidney Int. 2004, 66 (5), 2032-2037.
16. Roger Qiu, S.; Wierzbicki, A.; Alan Salter, E.; Zepeda, S.; Orme, C. A.; Hoyer, J. R.; Nancollas, G. H.; Cody, A. M.; De Yoreo, J. J. Modulation of Calcium Oxalate Monohydrate Crystallization by Citrate through Selective Binding to Atomic Steps. J. Am. Chem. Soc. 2005, 127 (25), 9036-9044.
17. Tiselius, H. G.; Berg, C.; Fornander, A. M.; Nilsson, M. A. Effects of Citrate on the Different Phases of Calcium Oxalate Crystallization. Scanning Microsc. 1993, 7(1), 381-389.
18. Chow, K.; Dixon, J.; Gilpin, S.; Kavanagh, J. P.; Rao, P. N. Citrate Inhibits Growth of Residual Fragments in an In Vitro Model of Calcium Oxalate Renal Stones. Kidney Int. 2004, 65 (5), 1724-1730.
19. Wang, L.; Zhang, W.; Roger Qiu, S.; Zachowicz, W. J.; Guan, X.; Tang, R.; Hoyer, J. R.; De Yoreo, J. J.; Nancollas, G. H. Inhibition of Calcium Oxalate Monohydrate Crystallization by the Combination of Citrate and Osteopontin. J. Cryst. Growth 2006, 291 (1), 160-165.
20. Weaver, M. L.; Roger Qiu, S.; Hoyer, J. R.; Casey, W. H.; Nancollas, G. H.; De Yoreo, J. J. Inhibition of Calcium Oxalate Monohydrate Growth by Citrate and the Effect of the Background Electrolyte. J. Cryst. Growth 2007, 306 (1), 135-145.
21. Kok, D.J.; Papapoulos, S. E.; Bijvoet, O. L. M. Excessive Crystal Agglomeration with Low Citrate Excretion in Recurrent Stone-Formers. The Lancet 1986, 327 (8489), 1056-1058.
22. Wierzbicki, A.; Sikes, C. S.; Sallies, J. D.; Madura, J. D.; Stevens, E. D.; Martin, K. L. Scanning Electron Microscopy and Molecular Modeling of Inhibition of Calcium Oxalate Monohydrate Crystal Growth by Citrate and Phosphocitrate. Calcif. Tissue Int. 1995, 56 (4), 297-304.
23. Hodgkinson, A. Relations between Oxalic Acid, Calcium, Magnesium and Creatinine Excretion in Normal Men and Male Patients with Calcium Oxalate Kidney Stones. Clin. Sci. Mol. Med. 1974, 46 (3), 357-367.
24. Wunderlich, W. Aspects of the Influence of Magnesium Ions on the Formation of Calcium Oxalate. Urol. Res. 1981, 9 (4), 157-161.
25. Lieske, J. C.; Farell, G.; Deganello, S. The Effect of Ions at the Surface of Calcium Oxalate Monohydrate Crystals on Cell-Crystal Interactions. Urol. Res. 2004, 32 (2), 117-123.
26. Li, S.; Sun, D. M.; Wu, Q. S.; Ding, Y. P. Simultaneous Synthesis of Different Structures of Calcium Oxalate by Living Bi-Template. Cryst. Res. Technol. 2008, 43 (7), 740-744.
27. Akin, B.; Öner, M.; Bayram, Y.; Demadis, K. D. Effects of Carboxylate-Modified, “Green” Inulin Biopolymers on the Crystal Growth of Calcium Oxalate. Cryst. Growth Des. 2008, 8 (6), 1997-2005.
28. Benítez, I. O.; Talham, D. R. Brewster Angle Microscopy of Calcium Oxalate Monohydrate Precipitation at Phospholipid Monolayer Phase Boundaries. Langmuir 2004, 20 (19), 8287-8293.
29. Backov, R.; Lee, C. M.; Khan, S.; Mingotaud, C.; Fanucci, G. E.; Talham, D. R. Calcium Oxalate Monohydrate Precipitation at Phosphatidylglycerol Langmuir Monolayers. Langmuir 2000, 16 (14), 6013-6019.
30. Sayan, P.; Sargut Titiz, S.; Kiran, B. Calcium Oxalate Crystallization in the Presence of Amino Acids, Proteins and Carboxylic Acids. Cryst. Res. Technol. 2009, 44 (8), 807-817.
31. Thurgood, L. A.; Cook, A. F.; Sørensen, E. S.; Ryall, R. L. Face-Specific Incorporation of Osteopontin into Urinary and Inorganic Calcium Oxalate Monohydrate and Dihydrate Crystals. Urol. Res. 2010, 38 (5), 357-376.
32. Weaver, M. L.; Qiu, S. R.; Friddle, R. W.; Casey, W. H.; De Yoreo, J. J. How the Overlapping Time Scales for Peptide Binding and Terrace Exposure Lead to Nonlinear Step Dynamics During Growth of Calcium Oxalate Monohydrate. Cryst. Growth Des. 2010, 10 (7), 2954-2959.
33. Letellier, S. R.; Lochhead, M. J.; Campbell, A. A.; Vogel, V. Oriented Growth of Calcium Oxalate Monohydrate Crystals Beneath Phospholipid Monolayers. Biochim. Biophys. Acta 1998, 1389 (1), 31-45.
34. Shirane, Y.; Kurokawa, Y.; Miyashita, S.; Komatsu, H.; Kagawa, S. Study of Inhibition Mechanisms of Glycosaminoglycans on Calcium Oxalate Monohydrate Crystals by Atomic Force Microscopy. Urol. Res. 1999, 27 (6), 426-431.
35. Jung, T.; Kim, W. S.; Choi, C. K. Crystal Structure and Morphology Control of Calcium Oxalate Using Biopolymeric Additives in Crystallization. J. Cryst. Growth 2005, 279 (1-2), 154-162.
36. Masui, M.; Suzuki, M.; Fujise, Y.; Kanayama, N. Calcium-Induced Changes in Chrondroitin Sulfate Chains of Urinary Trypsin Inhibitor. Biochim. Biophys. Acta 2001, 1546 (2), 261-267.
37. Honda, M.; Yoshioka, T.; Yamaguchi, S.; Yoshimura, K.; Miyake,O.; Utsunomiya, M.; Koide, T.; Okuyama, A. Characterization of Protein Components of Human Urinary Crystal Surface Binding Substance. Urol. Res. 1997, 25 (5), 355-360.
38. Hess, B.; Nakagawa, Y.; Coe, F. L. Inhibition of Calcium Oxalate Monohydrate Crystal Aggregation by Urine Proteins. AJP-Renal Physiol. 1989, 257 (1), F99-F106.
39. Deganello, S. The Interaction between Nephrocalcin and Tamm-Horsfall Proteins with Calcium Oxalate Dihydrate. Scanning Microsc. 1993, 7 (3), 1111-1118.
40. Grases, F.; Costa-Bauzá; March, J. G.; Masárová, L. Glycosaminoglycans, Uric Acid and Calcium Oxalate Urolithiasis. Urol. Res. 1991, 19(6), 375-380.
41. Grases, F.; Gil, J. J.; Conte, A. Glycosaminoglycans: Inhibition of Calcium Oxalate Crystalline Growth and Promotion of Crystal Aggregation. Colloids Surf. 1989, 36(1), 29-38.
42. Jung, T.; Sheng, X.; Choi, C. K.; Kim, W. S.; Wesson, J. A.; Ward, M. D. Probing Crystallization of Calcium Oxalate Monohydrate and the Role of Macromolecule Additives with In Situ Atomic Force Microscopy. Langmuir 2004, 20 (20), 8587-8596.
43. Ouyang, J. M.; Deng, S. P.; Zhong, J. P.; Tieke, B.; Yu, S. H. Crystallization of Calcium Oxalate Monohydrate at Dipalmitoylphosphatidylcholine Monolayers in the Presence of Chondroitin Sulfate A. J. Cryst. Growth 2004, 270 (3-4), 646-654.
44. Guo, S.; Ward, M. D.; Wesson, J. A. Direct Visualization of Calcium Oxalate Monohydrate Crystallization and Dissolution with Atomic Force Microscopy and the Role of Polymeric Additives. Langmuir 2002, 18 (11), 4282-4291.
45. Akyol, E.; Öner, M. Inhibition of Calcium Oxalate Monohydrate Crystal Growth Using Polyelectrolytes. J. Cryst. Growth 2007, 307 (1), 137-144.
46. Koide, T.; Takemoto, M.; Itatani, H.; Takaha, M.; Sonoda, T. Urinary Macromolecular Substances as Natural Inhibitors of Calcium Oxalate Crystal Aggregation. Invest. Urol. 1981, 18 (5), 382-386.
47. Angell, A. H.; Resnick, M. I. Surface Interaction Between Glycosaminoglycans and Calcium Oxalate. J. Urol. 1989, 141 (5), 1255-1258.
48. Fellström, B.; Danielson, B. G.; Ljunghall, S.; Wikström, B. Crystal Inhibition: The Effects of Polyanions on Calcium Oxalate Crystal Growth. Clin. Chim. Acta 1986, 158 (3), 229-235.
49. Rodgers, A. L.; Ball, D.; Harper, W. Urinary Macromolecules Are Promoters of Calcium Oxalate Nucleation in Human Urine: Turbidimetric Studies. Clin. Chim. Acta 1993, 220(2), 125-134.
50. Wesson, J. A.; Worcester, E. M.; Wiessner, J. H.; Mandel, N. S. Control of Calcium Oxalate Crystal Structure and Cell Adherence by Urinary Macromolecules. Kidney Int. 1998, 53 (4), 952-957.
51. Bouropoulos, C.; Vagenas, N.; Klepetsanis, P.; Stavropoulos, N.; Bouropoulos, N. Growth of Calcium Oxalate Monohydrate on Uric Acid Crystals at Sustained Supersaturation. Cryst. Res. Technol. 2004, 39 (8), 699-704.
52. Streit, J.; Tran-Ho, L.-C.; Königsberger, E. Solubility of the Three Calcium Oxalate Hydrate in Sodium Chloride Solutions and Urine-Like Liquors. Monatshefte für Chemie 1998, 129 (12), 1225-1236.
53. Opalko, F. J.; Adair, J. H.; Khan, S. R. Heterogeneous Nucleation of Calcium Oxalate Trihydarte in Artificial Urine by Constant Composition. J. Cryst. Growth 1997, 181 (4), 410-417.
54. Laube, N.; Pullmann, M.; Hergarten, S.; Hesse, A. Influence of Urinary Stones on the Composition of a 24-hour Urine Sample. Clinic. Chem. 2003, 49 (2), 281-285.
55. Callejas-Fernández, J.; Martínez-García, R.; Hidalgo-Alvarez, R.; de las Nieves, F. J. Effect of Some Inhibitors on the Zeta-Potential of Calcium Oxalate Monohydrate Particles. Prog. Colloid Polym. Sci. 1993, 93, 210-215.
56. Tiselius, H. G.; Fornander, A. M.; Nilsson, M. A. Inhibition of Calcium Oxalate Crystallization in Urine. Urol. Res. 1987, 15(2), 83-86.
57. Sommer, A. P.; Kajander, E. O. Nanobacteria-Induced Kidney Stone Formation: Novel Paradigm Based on the FERMIC Model. Cryst. Growth Des. 2002, 2(6), 563-565.
58. Wang, L.; Nancollas, G. H. Calcium Orthophosphates: Crystallization and Dissolution. Chem. Rev. 2008, 108 (11), 4628-4669.
59. Tiselius, H. G.; Larsson, L. Calcium Phosphate: An Important Crystal Phase in Patients with Recurrent Calcium Stone Formation? Urol. Res. 1993, 21 (3), 175-180.
60. Chou, Y. H.; Wang, H. S.; Li, C. C. Clinical analysis of patients with urinary calcium phosphate stones. J. Taiwan Urol. Assoc. 2009, 20 (1), 21-24.
61. Göbel, C.; Simon, P.; Buder, J.; Tlatlik, H.; Kniep, R. Phase Formation and Morphology of Calcium Phosphate-Gelatine-Composites Grown by Double Diffusion Technique: The Influence of Fluoride. J. Mater. Chem. 2004, 14(14), 2225-2230.
62. Joshi, V. S.; Joshi, M. J. FTIR Spectroscopic, Thermal and Growth Morphological Studies of Calcium Hydrogen Phosphate Dihydrate Crystals. Cryst. Res. Technol. 2003, 38 (9), 817-821.
63. Zahn, D. Mechanisms of Calcium and Phosphate Ion Association in Aqueous Solution. Z. Anorg. Allg. Chem. 2004, 630 (10), 1507-1511.
64. Grases, F.; Söhnel, O.; Vilacampa, A. I.; March, J. G. Phosphates Precipitating from Artificial Urine and Fine Structure of Phosphate Renal Calculi. Clin. Chim. Acta 1996, 244 (1), 45-67.
65. Bigi, A.; Falini, G..; Foresti, E.; Gazzano, M.; Ripamonti, A.; Roveri, N. Magnesium Influence on Hydroxyapatite Crystallization. J. Inorg. Biochem. 1993, 49 (1), 69-78.
66. Ebisuno, S.; Kohjimoto, Y.; Yoshida, T.; Ohkawa, T. Effect of Urinary Macromolecules on Aggregation of Calcium Oxalate in Recurrent Calcium Stone Formers and Healthy. Urol. Res. 1993, 21 (4), 265-268.
67. Cody, A. M.; Cody, R. D. Calcium Oxalate Trihydrate Phase Control by Structurally-Specific Carboxylic Acids. J. Cryst. Growth 1994, 135 (1-2), 235-245.
68. Wang, H.; Lee, J.-K.; Moursi, A.; Lannutti, J. J. Ca/P Ratio Effects on the Degradation of Hydroxyapatite In Vitro. J. Biomed. Mater. Res. Part A 2003, 67A (2), 599-608.
69. Boistelle, R.; Lopez-Valero, I.; Abbona, F. Crystallization of Calcium Phosphate in the Presence of Magnesium. Nephrologie 1993, 14 (6), 265-269.
70. Meyer, J. L.; Nancollas, G. H. The Effect of pH and Temperature on the Crystal Growth of Hydroxyapatite. Archs. Oral Biol. 1972, 17 (11), 1623-1627.
71. Shi Y.; Evans J. E.; Rock K.L. Molecular Identification of A Danger Signal That Alerts The Immune System to Dying Cells, Nature, 2003, 425(6957), 516-521.
72. Prien E. L. Studies in Urolithiasis. III. Physicochemical Principles in Stone Formation and Prevention, J. Urol., 1955, 73(4), 627-652.
73. Khan, S. R. Calcium Phosphate/Calcium Oxalate Crystal Association in Urinary Stones: Implications for Heterogeneous Nucleation of Calcium Oxalate. J. Urol. 1997, 157(1), 376-383.
74. Trinchieri, A.; Castelnuovo, C.; Lizzano, R.; Zanetti, G. Calcium Stone Disease: A Multiform Reality. Urol. Res. 2005, 33 (3), 194-198.
75. Schweizer, S.; Taubert, A. Polymer-Controlled, Bio-Inspired Calcium Phosphate Mineralization from Aqueous Solution. Macromol. Biosci. 2007, 7 (9-10), 1085-1099.
76. Heijnen, W.; Jellinghaus, W.; Klee, W. E. Calcium Oxalate Trihydrate in Urinary Calculi. Urol. Res. 1985, 13 (6), 281-283.
77. Abboud, I. A. Mineralogy and Chemistry of Urinary Stones: Patients from North Jordan. Environ. Geochem. Health 2008, 30(5), 445–463.
1. Grant, D. J. W. Polymorphism in pharmaceutical solids; Marcel Dekker, Inc.: New York, 1999; pp.1-21.
2. Threlfall, T. L. Analysis of organic polymorphs: a review, Analyst, 1995, 120(10), 2435-2460.
3. Koradia, V.; Chawla, G.; Bansal, A. K. Qualitive and quantitative analysis of clopidogrel bisulphate polymorphs. Acta Pharm. 2004, 54(3), 193-204.
4. Chawala G.; Bansal, A. K. Challenges in polymorphism of pharmaceuticals. CRIP, 2004, 5(1), 9-12.
5. Mirza, S.; Miroshnyk, I.; Heinamaki, J.; Christiansen, L.; Karjalainen, M.; Yliruusi, J. Influence of solvents on the variety of crystalline forms of erythromycin. AAPS Pharm. Sci. 2003, 5(3), 1-9.
6. Nichols, G.; Frampton, C. S. Physicochemical characterization of the orthorhombic polymorph of paracetamol crystallized from solution. J. Pharm. Sci. 1998, 87(6), 684-693.
7. Yu, L.; Reutzel, S. M.; Stephenson, G. A. Physical characterization of polymorphic drugs: an integrated characterization strategy. PSTT 1998, 1(3), 118-127.
8. Pavia, D. L.; Lampman, G. M.; Kriz, G. S. Infrared Spectroscopy; Brooks/COLE Thomson Learning: USA, 2001; pp13-24.
9. Gotoh, K.; Masuda, H.; Higashitani, K. Powder technology handbook, Marcel Dekker, Inc: New York, 1997; p 92.
10. Skoog, D. A.; Holler, F. J.; Crouch, S. R. Principles of Instrumental Analysis; Thomson Learning: USA, 2007; pp 955-958.
11. Cölle, M.; Gmeiner, J.; Milius, W.; Hillebrecht, H.; Brütting, W. Preparation and characterization of blue-luminescent tris(8-hydroxyquinoline)-aluminum (Alq3). Adv. Funct. Mater. 2003, 13(2), 108-112.
12. Macur, J. E.; Marti, J.; Lui, S. C. Matericals Characterization and Chemical Analysis; Wiley-Vch: New York, 1996; pp 167-177.
13. Gotoh, K.; Masuda, H.; Higashitani, K. Powder technology handbook, Marcel Dekker, Inc: New York, 1997; pp 413-730.
14. Skoog, D. A.; Holler, F. J.; Crouch, S. R. Principles of Instrumental Analysis; Thomson Learning: USA, 2007; pp 608-613.
15. Reed-hill, R. E. Physical Metallurgy Principles; PWS Publishing Company: Boston 1994; pp53-60.
16. Russell, S. D.; Daghlian, C. P. Scanning electron microscopic observations on deembedded biological tissue sections: comparison of different fixatives and embedding materials. J. Electron. Microsc. Tech. 1985, 2(5), 489-495.
17. Smith, W. F. Foundations of Materials Science and Engineering; McGraw-Hill Company: USA, 2004; pp 147-149.
18. Haines, P. J.; Wiburn, F. W. Thermal Analysis and Differential Scanning Calorimetry, Applications and Problems; Blackie Academic and Professional: New York 1995; pp 63-89.
19. Boldyerva, E. V.; Drebushchak, V. A.; Paukov, I. E.; Kovalevskaya, Y. A.; Drebushchak, T. N. DSC and adiabatic calorimetry study of the polymorphs of paracetamol. J. of Them. Anal. Calor. 2004, 77(2), 607-623.
20. Skoog, D. A.; Holler, F. J.; Crouch, S. R. Principles of Instrumental Analysis, Thomson Learning: USA, 2007; pp 894-904.
21. Rouessac, F.; Rouessac, A. Infrared Spectroscopy; John Willy & Sons: Chichester, 2001; pp 170-173.
22. Skoog, D. A.; Holler, F. J.; Crouch, S. R. Principles of Instrumental Analysis; Thomson Learning: Mississippi, 2007; pp 204-211.
23. Bauer-Brandl, A. Polymorphic transitions of cimetidine during manufacture of solid dosage forms. Int. J. Pharm. 1996, 140(2), 195-206.
24. Murthy, N. S.; Reidinger, F. Matericals Characterization and Chemical Analysis; Wiley-Vch Publishers: New York, 1996; pp 143-149.
25. Davidovich, M.; Dimarco, J.; Gougoutas, J. Z.; Scaringe, R. P.; Vitez, I.; Yin, S. Detection of polymorphic artifacts in powder x-ray diffraction determination. Am. Pharm. Rev. 1996, 138 (1), 1-2.
26. Smith, W. F. Foundations of Materials Science and Engineering; McGraw-Hill Company: USA, 2004; pp 99-101.
1. Lonsdale, K. Human Stones. Science 1968, 159 (3820), 1199-1207.
2. Parmar, M. S. Kidney Stone. Br. Med. J. 2004, 328(7453),1420-1424.
3. Herring, L. C. Observations on the Analysis of Ten Thousand Urinary Calculi. J. Urol. 1962, 88 (4), 545-562.
4. Khan, S. R. Calcium Phosphate/Calcium Oxalate Crystal Association in Urinary Stones: Implications for Heterogeneous Nucleation of Calcium Oxalate. J. Urol. 1997, 157(1), 376-383.
5. Trinchieri, A.; Castelnuovo, C.; Lizzano, R.; Zanetti, G. Calcium Stone Disease: A Multiform Reality. Urol. Res. 2005, 33 (3), 194-198.
6. Schweizer, S.; Taubert, A. Polymer-Controlled, Bio-Inspired Calcium Phosphate Mineralization from Aqueous Solution. Macromol. Biosci. 2007, 7 (9-10), 1085-1099.
7. Heijnen, W.; Jellinghaus, W.; Klee, W. E. Calcium Oxalate Trihydrate in Urinary Calculi. Urol. Res. 1985, 13 (6), 281-283.
8. Wang, L.; Nancollas, G. H. Calcium Orthophosphates: Crystallization and Dissolution. Chem. Rev. 2008, 108 (11), 4628-4669.
9. Tiselius, H. G.; Larsson, L. Calcium Phosphate: An Important Crystal Phase in Patients with Recurrent Calcium Stone Formation? Urol. Res. 1993, 21 (3), 175-180.
10. Iwata, H.; Nishio, S.; Wakatsuki, A.; Ochi, K.; Takeuchi, M. Architecture of Calcium Oxalate Monohydrate Urinary Calculi. J. Urol. 1985, 133 (2), 334-338.
11. Abboud, I. A. Mineralogy and Chemistry of Urinary Stones: Patients from North Jordan. Environ. Geochem. Health 2008, 30(5), 445–463.
12. Finlayson, B.; Reid, F. The Expectation of Free and Fixed Particles in Urinary Stone Disease. Investig. Urol. 1978, 15(6), 442-448.
13. Madsen, K. M.; Verlander, J. W.; Tisher, C. C. Relationship Between Structure and Function in Distal Tubule and Collecting Duct. J. Electron Microsc. Tech. 1988, 9(2), 187-208.
14. Kok, D. J.; Khan, S. R. Calcium Oxalate Nephrolithiasis, a Free or Fixed Particle Disease. Kidney Int. 1994, 46 (3), 847-854.
15. Al-Atar, U.; Bokov, A. A.; Marshall, D.; Teichman, J. M. H.; Gates, B. D.; Ye, Z. G.; Branda, N. R. Mechanism of Calcium Oxalate Monohydrate Kidney Stones Formation: Layered Spherulitic Growth. Chem. Mater. 2010, 22 (4), 1318-1329.
16. Baumann, J. M. Can the Formation of Calcium Oxalate Stones Be Explained by Crystallization Processes in Urine? Urol. Res. 1985, 13 (6), 267-270.
17. Meyer, J. M.; Smith, L. H. Growth of Calcium Oxalate Crystals I. A Model for Urinary Stone Growth. Invest. Urol. 1975, 13(1), 31-35.
18. Tsujihata, M. Mechanism of Calcium Oxalate Renal Stone Formation and Renal Tubular Cell Injury. Inter. J. Urol. 2008, 15 (2), 115-120.
19. Ebrahimpour, A.; Perez, L.; Nancollas, G. H. Induced Crystal Growth of Calcium Oxalate Monohydrate at Hydroxyapatite Surfaces. The Influence of Human Serum Albumin, Citrate, and Magnesium. Langmuir 1991, 7 (3), 577-583.
20. Khan, S. R.; Glenton, P. A. Calcium Oxalate Crystal Deposition in Kidneys of Hypercalciuric Mice with Disrupted Type IIa Sodium-Phosphate Co-Transporter. Am. J. Physiol. Renal. Physiol. 2008, 294 (5), F1109-F1115.
21. Prien, E. L. Studies in Urolithiasis: III. Physicochemical Principles in Stone Formation and Preservation. J. Urol. 1955, 73 (4), 627-652.
22. Pak, C. Y. C. Physiochemical Basis for Formation of Renal Stones of Calcium Phosphate Origin: Calculation of the Degree of Saturation of Urine with Respect to Brushite. J. Clin. Invest. 1969, 48 (10), 1914-1922.
23. Will, E. J.; Bijvoet, O. L. M.; Blomen, L. J. M. J.; van der Linden, H. Growth Kinetics of Calcium Oxalate Monohydrate. I. Method and Validation. J. Cryst. Growth 1983, 64 (2), 297-305.
24. Blomen, L. J. M. J.; Will, E. J.; Bijvoet, O. L. M.; van der Linden, H. Growth Kinetics of Calcium Oxalate Monohydrate. II. The Variation of Seed Concentration. J. Cryst. Growth 1983, 64 (2), 306-315.
25. Bijvoet, O. L. M.; Blomen, L. J. M. J.; Will, E. J.; van der Linden, H. Growth Kinetics of Calcium Oxalate Monohydrate. III. Variation of Solution. J. Cryst. Growth 1983, 64 (2), 316-325.
26. El-Shall, H.; Jeon, J. H.; Abdel-Aal, E. A.; Khan, S.; Gower, L.; Rabinovich, Y. A Study of Primary Nucleation of Calcium Oxalate Monohydrate: I. Effect of Supersaturation. Cryst. Res. Technol. 2004, 39 (3), 214-221.
27. El-Shall, H.; Jeon, J. H.; Abdel-Aal, E. A.; Khan, S.; Gower, L.; Rabinovich, Y. A Study of Primary Nucleation of Calcium Oxalate Monohydrate: II. Effect of Urinary Species. Cryst. Res. Technol. 2004, 39 (3), 222-229.
28. Hacherl, J. M.; Paul, E. L.; Buettner, H. M. Investigation of Imaging-Jet Crystallization with a Calcium Oxalate Model System. AIChE Journal 2003, 49 (9), 2352-2362.
29. Kok, D. J.; Papapoulos, S. E.; Bijvoet, O. L. M. Crystal Agglomeration is a Major Element in Calcium Oxalate Urinary Stone Formation. Kidney Int. 1990, 37 (1), 51-56.
30. Kok, D. J.; Papapoulos, S. E.; Blomen, L. J. M. J.; Bijvoet, O. L. M. Modulation of Calcium Oxalate Monohydrate Crystallization Kinetics In Vitro. Kidney Int. 1988, 34 (3), 346-350.
31. Štulajterová, R.; Medvecký, Ľ. Effect of Calcium Ions on Transformation Brushite to Hydroxyapatite in Aqueous Solutions. Colloids and Surfaces A: Physicochem. Eng. Aspects 2008, 316 (1-3), 104-109.
32. Pak, C. Y. C.; Adams-Huet, B.; Poindexter, J. R.; Pearle, M. S.; Peterson, R. D.; Moe, O. W. Relative Effect of Urinary Calcium and Oxalate on Saturation of Calcium Oxalate. Kidney Int. 2004, 66 (5), 2032-2037.
33. Roger Qiu, S.; Wierzbicki, A.; Alan Salter, E.; Zepeda, S.; Orme, C. A.; Hoyer, J. R.; Nancollas, G. H.; Cody, A. M.; De Yoreo, J. J. Modulation of Calcium Oxalate Monohydrate Crystallization by Citrate through Selective Binding to Atomic Steps. J. Am. Chem. Soc. 2005, 127 (25), 9036-9044.
34. Tiselius, H. G.; Berg, C.; Fornander, A. M.; Nilsson, M. A. Effects of Citrate on the Different Phases of Calcium Oxalate Crystallization. Scanning Microsc. 1993, 7 (1) 381-389.
35. Chow, K.; Dixon, J.; Gilpin, S.; Kavanagh, J. P.; Rao, P. N. Citrate Inhibits Growth of Residual Fragments in an In Vitro Model of Calcium Oxalate Renal Stones. Kidney Int. 2004, 65 (5), 1724-1730.
36. Wang, L.; Zhang, W.; Roger Qiu, S.; Zachowicz, W. J.; Guan, X.; Tang, R.; Hoyer, J. R.; De Yoreo, J. J.; Nancollas, G. H. Inhibition of Calcium Oxalate Monohydrate Crystallization by the Combination of Citrate and Osteopontin. J. Cryst. Growth 2006, 291 (1), 160-165.
37. Weaver, M. L.; Roger Qiu, S.; Hoyer, J. R.; Casey, W. H.; Nancollas, G. H.; De Yoreo, J. J. Inhibition of Calcium Oxalate Monohydrate Growth by Citrate and the Effect of the Background Electrolyte. J. Cryst. Growth 2007, 306 (1), 135-145.
38. Kok, D.J.; Papapoulos, S. E.; Bijvoet, O. L. M. Excessive Crystal Agglomeration with Low Citrate Excretion in Recurrent Stone-Formers. The Lancet 1986, 327 (8489), 1056-1058.
39. Wierzbicki, A.; Sikes, C. S.; Sallies, J. D.; Madura, J. D.; Stevens, E. D.; Martin, K. L. Scanning Electron Microscopy and Molecular Modeling of Inhibition of Calcium Oxalate Monohydrate Crystal Growth by Citrate and Phosphocitrate. Calcif. Tissue Int. 1995, 56 (4), 297-304.
40. Hodgkinson, A. Relations between Oxalic Acid, Calcium, Magnesium and Creatinine Excretion in Normal Men and Male Patients with Calcium Oxalate Kidney Stones. Clin. Sci. Mol. Med. 1974, 46 (3), 357-367.
41. Wunderlich, W. Aspects of the Influence of Magnesium Ions on the Formation of Calcium Oxalate. Urol. Res. 1981, 9 (4), 157-161.
42. Lieske, J. C.; Farell, G.; Deganello, S. The Effect of Ions at the Surface of Calcium Oxalate Monohydrate Crystals on Cell-Crystal Interactions. Urol. Res. 2004, 32 (2), 117-123.
43. Li, S.; Sun, D. M.; Wu, Q. S.; Ding, Y. P. Simultaneous Synthesis of Different Structures of Calcium Oxalate by Living Bi-Template. Cryst. Res. Technol. 2008, 43 (7), 740-744.
44. Akin, B.; Öner, M.; Bayram, Y.; Demadis, K. D. Effects of Carboxylate-Modified, “Green” Inulin Biopolymers on the Crystal Growth of Calcium Oxalate. Cryst. Growth Des. 2008, 8 (6), 1997-2005.
45. Benítez, I. O.; Talham, D. R. Brewster Angle Microscopy of Calcium Oxalate Monohydrate Precipitation at Phospholipid Monolayer Phase Boundaries. Langmuir 2004, 20 (19), 8287-8293.
46. Backov, R.; Lee, C. M.; Khan, S.; Mingotaud, C.; Fanucci, G. E.; Talham, D. R. Calcium Oxalate Monohydrate Precipitation at Phosphatidylglycerol Langmuir Monolayers. Langmuir 2000, 16 (14), 6013-6019.
47. Sayan, P.; Sargut Titiz, S.; Kiran, B. Calcium Oxalate Crystallization in the Presence of Amino Acids, Proteins and Carboxylic Acids. Cryst. Res. Technol. 2009, 44 (8), 807-817.
48. Thurgood, L. A.; Cook, A. F.; Sørensen, E. S.; Ryall, R. L. Face-Specific Incorporation of Osteopontin into Urinary and Inorganic Calcium Oxalate Monohydrate and Dihydrate Crystals. Urol. Res. 2010, 38 (5), 357-376.
49. Weaver, M. L.; Qiu, S. R.; Friddle, R. W.; Casey, W. H.; De Yoreo, J. J. How the Overlapping Time Scales for Peptide Binding and Terrace Exposure Lead to Nonlinear Step Dynamics During Growth of Calcium Oxalate Monohydrate. Cryst. Growth Des. 2010, 10 (7), 2954-2959.
50. Letellier, S. R.; Lochhead, M. J.; Campbell, A. A.; Vogel, V. Oriented Growth of Calcium Oxalate Monohydrate Crystals Beneath Phospholipid Monolayers. Biochim. Biophys. Acta 1998, 1389 (1), 31-45.
51. Shirane, Y.; Kurokawa, Y.; Miyashita, S.; Komatsu, H.; Kagawa, S. Study of Inhibition Mechanisms of Glycosaminoglycans on Calcium Oxalate Monohydrate Crystals by Atomic Force Microscopy. Urol. Res. 1999, 27 (6), 426-431.
52. Jung, T.; Kim, W. S.; Choi, C. K. Crystal Structure and Morphology Control of Calcium Oxalate Using Biopolymeric Additives in Crystallization. J. Cryst. Growth 2005, 279 (1-2), 154-162.
53. Masui, M.; Suzuki, M.; Fujise, Y.; Kanayama, N. Calcium-Induced Changes in Chrondroitin Sulfate Chains of Urinary Trypsin Inhibitor. Biochim. Biophys. Acta 2001, 1546 (2), 261-267.
54. Honda, M.; Yoshioka, T.; Yamaguchi, S.; Yoshimura, K.; Miyake,O.; Utsunomiya, M.; Koide, T.; Okuyama, A. Characterization of Protein Components of Human Urinary Crystal Surface Binding Substance. Urol. Res. 1997, 25 (5), 355-360.
55. Hess, B.; Nakagawa, Y.; Coe, F. L. Inhibition of Calcium Oxalate Monohydrate Crystal Aggregation by Urine Proteins. AJP-Renal Physiol. 1989, 257 (1), F99-F106.
56. Deganello, S. The Interaction between Nephrocalcin and Tamm-Horsfall Proteins with Calcium Oxalate Dihydrate. Scanning Microsc. 1993, 7 (3), 1111-1118.
57. Grases, F.; Costa-Bauzá; March, J. G.; Masárová, L. Glycosaminoglycans, Uric Acid and Calcium Oxalate Urolithiasis. Urol. Res. 1991, 19(6), 375-380.
58. Grases, F.; Gil, J. J.; Conte, A. Glycosaminoglycans: Inhibition of Calcium Oxalate Crystalline Growth and Promotion of Crystal Aggregation. Colloids Surf. 1989, 36(1), 29-38.
59. Jung, T.; Sheng, X.; Choi, C. K.; Kim, W. S.; Wesson, J. A.; Ward, M. D. Probing Crystallization of Calcium Oxalate Monohydrate and the Role of Macromolecule Additives with In Situ Atomic Force Microscopy. Langmuir 2004, 20 (20), 8587-8596.
60. Ouyang, J. M.; Deng, S. P.; Zhong, J. P.; Tieke, B.; Yu, S. H. Crystallization of Calcium Oxalate Monohydrate at Dipalmitoylphosphatidylcholine Monolayers in the Presence of Chondroitin Sulfate A. J. Cryst. Growth 2004, 270 (3-4), 646-654.
61. Guo, S.; Ward, M. D.; Wesson, J. A. Direct Visualization of Calcium Oxalate Monohydrate Crystallization and Dissolution with Atomic Force Microscopy and the Role of Polymeric Additives. Langmuir 2002, 18 (11), 4282-4291.
62. Akyol, E.; Öner, M. Inhibition of Calcium Oxalate Monohydrate Crystal Growth Using Polyelectrolytes. J. Cryst. Growth 2007, 307 (1), 137-144.
63. Koide, T.; Takemoto, M.; Itatani, H.; Takaha, M.; Sonoda, T. Urinary Macromolecular Substances as Natural Inhibitors of Calcium Oxalate Crystal Aggregation. Invest. Urol. 1981, 18 (5), 382-386.
64. Angell, A. H.; Resnick, M. I. Surface Interaction Between Glycosaminoglycans and Calcium Oxalate. J. Urol. 1989, 141 (5), 1255-1258.
65. Fellström, B.; Danielson, B. G.; Ljunghall, S.; Wikström, B. Crystal Inhibition: The Effects of Polyanions on Calcium Oxalate Crystal Growth. Clin. Chim. Acta 1986, 158 (3), 229-235.
66. Rodgers, A. L.; Ball, D.; Harper, W. Urinary Macromolecules Are Promoters of Calcium Oxalate Nucleation in Human Urine: Turbidimetric Studies. Clin. Chim. Acta 1993, 220(2), 125-134.
67. Wesson, J. A.; Worcester, E. M.; Wiessner, J. H.; Mandel, N. S. Control of Calcium Oxalate Crystal Structure and Cell Adherence by Urinary Macromolecules. Kidney Int. 1998, 53 (4), 952-957.
68. Bouropoulos, C.; Vagenas, N.; Klepetsanis, P.; Stavropoulos, N.; Bouropoulos, N. Growth of Calcium Oxalate Monohydrate on Uric Acid Crystals at Sustained Supersaturation. Cryst. Res. Technol. 2004, 39 (8), 699-704.
69. Streit, J.; Tran-Ho, L.-C.; Königsberger, E. Solubility of the Three Calcium Oxalate Hydrate in Sodium Chloride Solutions and Urine-Like Liquors. Monatshefte für Chemie 1998, 129 (12), 1225-1236.
70. Opalko, F. J.; Adair, J. H.; Khan, S. R. Heterogeneous Nucleation of Calcium Oxalate Trihydarte in Artificial Urine by Constant Composition. J. Cryst. Growth 1997, 181 (4), 410-417.
71. Laube, N.; Pullmann, M.; Hergarten, S.; Hesse, A. Influence of Urinary Stones on the Composition of a 24-hour Urine Sample. Clinic. Chem. 2003, 49 (2), 281-285.
72. Callejas-Fernández, J.; Martínez-García, R.; Hidalgo-Alvarez, R.; de las Nieves, F. J. Effect of Some Inhibitors on the Zeta-Potential of Calcium Oxalate Monohydrate Particles. Prog. Colloid Polym. Sci. 1993, 93, 210-215.
73. Tiselius, H. G.; Fornander, A. M.; Nilsson, M. A. Inhibition of Calcium Oxalate Crystallization in Urine. Urol. Res. 1987, 15(2), 83-86.
74. Sommer, A. P.; Kajander, E. O. Nanobacteria-Induced Kidney Stone Formation: Novel Paradigm Based on the FERMIC Model. Cryst. Growth Des. 2002, 2(6), 563-565.
75. Chou, Y. H.; Wang, H. S.; Li, C. C. Clinical analysis of patients with urinary calcium phosphate stones. J. Taiwan Urol. Assoc. 2009, 20 (1), 21-24.
76. Göbel, C.; Simon, P.; Buder, J.; Tlatlik, H.; Kniep, R. Phase Formation and Morphology of Calcium Phosphate-Gelatine-Composites Grown by Double Diffusion Technique: The Influence of Fluoride. J. Mater. Chem. 2004, 14(14), 2225-2230.
77. Joshi, V. S.; Joshi, M. J. FTIR Spectroscopic, Thermal and Growth Morphological Studies of Calcium Hydrogen Phosphate Dihydrate Crystals. Cryst. Res. Technol. 2003, 38 (9), 817-821.
78. Zahn, D. Mechanisms of Calcium and Phosphate Ion Association in Aqueous Solution. Z. Anorg. Allg. Chem. 2004, 630 (10), 1507-1511.
79. Grases, F.; Söhnel, O.; Vilacampa, A. I.; March, J. G. Phosphates Precipitating from Artificial Urine and Fine Structure of Phosphate Renal Calculi. Clin. Chim. Acta 1996, 244 (1), 45-67.
80. Bigi, A.; Falini, G..; Foresti, E.; Gazzano, M.; Ripamonti, A.; Roveri, N. Magnesium Influence on Hydroxyapatite Crystallization. J. Inorg. Biochem. 1993, 49 (1), 69-78.
81. Ebisuno, S.; Kohjimoto, Y.; Yoshida, T.; Ohkawa, T. Effect of Urinary Macromolecules on Aggregation of Calcium Oxalate in Recurrent Calcium Stone Formers and Healthy. Urol. Res. 1993, 21 (4), 265-268.
82. Cody, A. M.; Cody, R. D. Calcium Oxalate Trihydrate Phase Control by Structurally-Specific Carboxylic Acids. J. Cryst. Growth 1994, 135 (1-2), 235-245.
83. Wang, H.; Lee, J.-K.; Moursi, A.; Lannutti, J. J. Ca/P Ratio Effects on the Degradation of Hydroxyapatite In Vitro. J. Biomed. Mater. Res. Part A 2003, 67A (2), 599-608.
84. Boistelle, R.; Lopez-Valero, I.; Abbona, F. Crystallization of Calcium Phosphate in the Presence of Magnesium. Nephrologie 1993, 14 (6), 265-269.
85. Meyer, J. L.; Nancollas, G. H. The Effect of pH and Temperature on the Crystal Growth of Hydroxyapatite. Archs. Oral Biol. 1972, 17 (11), 1623-1627.
86. Herrmann, U.; Schwille, P. O.; Kuch, P. Crystalluria Determined by Polarization Microscopy. Technique and Results in Healthy Control Subjects and Patients with Idiopathic Recurrent Calcium Urolithiasis Classified in Accordance with Calciuria. Urol. Res. 1991, 19 (3), 151-158.
87. Haselhuhn, F.; Kind, M. Pseudo-Polymorphic Behavior of Precipitated Calcium Oxalate. Chem. Eng. Technol. 2003, 26 (3), 347-353.
88. Grohe, B.; Rogers, K. A.; Goldberg, H. A.; Hunter, G.. K. Crystallization Kinetics of Calcium Oxalate Hydrates Studied by Scanning Confocal Interference Microscopy. J. Cryst. Growth 2006, 295 (2), 148-157.
89. Su, C.-J.; Shevock, P. N.; Khan, S. R.; Hackett, R. L. Effect of Magnesium on Calcium Oxalate Urolithiasis. J. Urol. 1991, 145 (5), 1092-1095.
90. Lieske, J. C.; Toback, F. G..; Deganello, S. Face-Selective Adhesion of Calcium Oxalate Dihydrate Crystals to Renal Epithelial Cells. Calcif. Tissue Int. 1996, 58 (3), 195-200.
91. Wesson, J. A.; Worcester, E. M.; Wiessner, J. H.; Mandel, N. S. Control of Calcium Oxalate Crystal Structure and Cell Adherence by Urinary Macromolecules. Kidney Int. 1998, 53 (4), 952-957.
92. Domrongkitchaiporn, S.; Stitchantrakul, W.; Kochakarn, W. Causes of Hypocitraturia in Recurrent Calcium Stone Formers: Focusing on Urinary Potassium Excretion. Am. J. Kidney Dis. 2006, 48 (4), 546-554.
93. Hallson, P. C.; Rose, G. A. Measurement of Calcium Phosphate Crystalluria: Influence of pH and Osmolality and Invariable Presence of Oxalate. Br. J. Urol. 1989, 64 (5), 458-462.
94. Boyce, W. H. Organic Matrix of Human Urinary Concretions. Am. J. Med. 1968, 45 (5), 673-683.
95. Højgaard, I.; Tiselius, H. G. Crystallization in the Nephron. Urol. Res. 1999, 27 (6), 397-403.
96. Meyer, J. L.; Bergert, J. H.; Smith, L. H. Epitaxial Relationships in Urolithiasis: The Calcium Oxalate Monohydrate-Hydroxyapatite System. Clin. Sci. Mol. Med. 1975, 49 (5), 369-374.
97. Lee, D.; Kumta, P. N. Chemical Synthesis and Stabilization of Magnesium Substituted Brushite. Mater. Sci. Eng. C 2010, 30 (7), 934-943.
98. Abbona, F.; Lundager Madsen, H. E.; Boistelle, R. Crystallization of Two Magnesium Phosphates, Struvite and Newberyite: Effect of pH and Concentration. J. Cryst. Growth 1982, 57 (1), 6-14.
1. oshi, V. S.; Joshi, M. J. FTIR Spectroscopic, Thermal and Growth Morphological Studies of Calcium Hydrogen Phosphate Dihydrate Crystals. Cryst. Res. Technol. 2003, 38 (9), 817-821.
2. Lee, D.; Kumta, P. N. Chemical Synthesis and Stabilization of Magnesium Substituted Brushite. Mater. Sci. Eng. C 2010, 30 (7), 934-943.
3. Rößler, S.; Sewing, A.; Stölzel, M.; Born, R.; Scharnweber, D.; Dard, M.; Worch, H. Electrochemically Assisted Deposition of Thin Calcium Phosphate Coatings at Near-Physiological pH and Temperature. J. Biomed. Mater. Res. A 2003, 64A(4), 655-663.
1. chweizer, S.; Taubert, A. Polymer-Controlled, Bio-Inspired Calcium Phosphate Mineralization from Aqueous Solution. Macromol. Biosci. 2007, 7 (9-10), 1085-1099
2. Wang, L.; Nancollas, G. H. Calcium Orthophosphates: Crystallization and Dissolution. Chem. Rev. 2008, 108 (11), 4628-4669.
1. Togkalidou T.; Braatz R. D.; Johnson B. K.; Davidson O.; Andrews A. Experimental Design and Inferential Modeling in Pharmaceutical Crystallization. AIChE J. 2001, 47(1), 160-168.
2. Lee T.; Kuo C. S.; Chen Y. H. Solubility, Polymorphism, Crystallinity, and Crystal Habit of Acetaminophen and Ibuprofen by Initial Solvent Screening. Pharm. Tech. 2006, 30(10), 72-92.
3. Akpalu Y.; Kielhorn L.; Hsiao B. S.; Stein R. S.; Russell T. P.; Egmond J. V.; Muthukumar M. Structure Development During Crystallization of Homogeneous Copolymers of Ethene and 1-octene: Time-resolved Synchrotron X-ray and SALS Measurements. Macromolecules 1999, 32(3), 765-770.
4. Ahari H.; Bedard R. L.; Bowes Carol L.; Coombs N.; Ozin G. A.; Petrov S.; Sokolov I.; Verma A.; Vovk G.; Young D. Effect of Microgravity on The Crystallization of A Selfassembling Layered Material. Nature 1997, 388(6645), 857-860.
5. Wright A. J.; Mcgauley S. E.; Narine S. S.; Willis W. M.; Lencki R.W.; Marangoni A. G. Solvent Effect on The Crystallization Behavior of Milk Fat Fractions. J. Agric. Food Chem. 2000, 48(4), 1033-1040.
6. Gotoh K.; Masuda H.; Higashitani K. Powder Technology Hand Book, 2nd ed.; Marcel Dekker: New York, USA, 1997; pp. 459-468.
7. Morissettea S. L.; Almarssona O.; Petersona M. L.; Remenara J. F.; Reada M. J.; Lemmoa A. V.; Ellisa S.; Cimab M. J.; Gardnera C. R. High-throughput Crystallization: Polymorphs, Salt, Co-crystals and Solvates of Pharmaceutical Solids. Adv. Drug Del. Rev. 2004, 56(3), 275-300.
8. Herring L. C. Observations on The Analysis of Ten Thousand Urinary Calculi. J. Urol. 1962, 88(4), 545-562.
9. Lee T.; Chen Y. H.; Zhang C. W Solubility, Polymorphism, Crystallinity, Crystal Habit, and Drying Scheme of (R, S)-(±)-Sodium Ibuprofen Dehydrate. Pharm. Tech. 2007, 31(6), 72-87.
10. Prien E. L. Studies in Urolithiasis. III. Physicochemical Principles in Stone Formation and Prevention. J. Urol. 1955, 73(4), 627-652.
11. Lonsdale K. Human Stones: Limited Studies Give Some Details of Composition, Rates of Growth, Distribution, and Possible Causes. Science 1968, 159(3820), 1199–1207.
12. Ouyang J. M.; Zhou N.; Duan L.; Tieke B. Ability of Multifunctional Sodium Carboxylates to Favor Crystal Growth of Calcium Oxalate Dihydrate and Trihydrate in Lecithin-water Liposome Systems. Colloid Surface Physicochem. Eng. Aspect. 2004, 245(1-3), 153-162.
13. Deganello S.; Kampf A. R.; Moore P. B. The Crystal Structure of Calcium Oxalate Trihydrate: Ca(H¬2O)3(C2O4). Am. Miner. 1981, 66(7-8), 859–865.
14. Streit J.; Tran-Ho L. C.; Königsberger E. Solubility of the Three Calcium Oxalate Hydrates in Sodium Chloride Solutionsand Urine-Like Liquors. Mon. Chem. 1998, 129(12), 1225-1236.
15. Akın B.; Öner M.; Bayram Y.; Demadis K. D. Effects of Carboxylate-Modified, “Green” Inulin Biopolymers on the Crystal Growth of Calcium Oxalate. Cryst. Growth Des, 2008, 8(6), 1997–2005.
16. Hochrein O.; Thomas A.; Kniep R. Revealing the Crystal Structure of Anhydrous Calcium Oxalate, Ca[C2O4], by a Combination of Atomistic Simulation and Rietveld Refinement. Z. Anorg. Allg. Chem. 2008, 634(11), 1826-1829.
17. Sayan P.; Sargut S. T.; Kiran B. Calcium Oxalate Crystallization in The Presence of Amino Acids, Proteins and Carboxylic Acids. Cryst. Res. Technol. 2009, 44(8), 807-817.
18. Heijnen W.; Jellinghaus W.; Klee W. E. Calcium Oxalate Trihydrate in Urinary Calculi. Urol. Res. 1985, 13(6), 281-283.
19. Bouropoulos C.; Vagenas N.; Klepetsanis P.; Bouropoulos N. Growth of Calcium Oxalate Monohydrate on Uric Acid Crystals at Sustained Supersaturation. Cryst. Res. Technol. 2004, 39(3), 699-704.
20. Tazzoli V.; Domeneghetti C. The Crystal Structures of Whewellite and Weddellite: Re-examination and Comparison. Am. Miner. 1980, 65(3-4), 327-334.
21. Brittain H. G.; Grant D. J. W. Polymorphism in Pharmaceutical Solids, Brttain H. G., Eds.; Marcel Dekker: New York, 1999; pp. 279-330.
22. Reichardt C. Solvents and Solvent Effects in Organic Chemistry, Reichardt C., Eds.; WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim: Germany, 2006; pp. 5-46.
23. Lubczak J.; Cisek-Cicirko I.; My liwiec B. Preparation and Applications of The Products of Reaction of Uric Acid with Formaldehyde. React. Funct. Polym. 2002, 53(2-3), 113-124.
24. Mullin J. W. Crystallization, 3rd ed.; Butterworth-Heinemann, Jordan Hill: UK, 1997; pp. 93, 248-250.
25. Martino P. D.; Beccerica M.; Joiris E.; Palmieri G. F.; Gayot A.; Martelli S. Influence of Crystal Habit on The Compression and Densification Mechanism of Ibuprofen. J. Crys. Growth 2002, 243(2), 345-355.
26. Winn D.; Doherty M. F. A New Technique for Predicting the Shape of Solution-Grown Organic Crystals. AlChE J. 1998, 44(11), 2501-2514.
27. Tiwary A. K. Modification of Crystal Habit and Its Role in Dosage form Performance. Drug Dev. Ind. Pharm. 2001, 27(7), 699–709.
28. Hilfiker R.; Blatter F.; Raumer M. V. Polymorphism in Pharmaceutical Industry, WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim: Germany, 2006; pp. 1-19.
29. Price C. J. Take Some Solid Steps to Improve Crystallization. Chem. Eng. Prog. 1997, 93(9), 34-43.
30. Rodriguez-Spong B.; Price C. P.; Jayasankar A.; Matzger A. J.; Rodriguez-Hornedo N. General Principles of Pharmaceutical Solid Polymorphism: a Supramolecular Perspective. Adv. Drug Del. Rev. 2004, 56(2), 241-271.
31. Threlfall T. Crystallization of Polymorphs: Thermodynamic Insight into The Role of Solvent. Org. Process Res. Dev. 2000, 4(5), 384-390.
32. Cardew P. T.; Davey R. J. The Kinetics of Solvent-mediated Phase Transformation. Math. Phys. Sci. 1985, 398(1815), 415-428.
33. Giron D. Thermal Analysis and Calorimetric Methods in The Characterization of
Polymorphs and Solvates. Thermochim. Acta 1995, 248(1), 1-59.
34. Shi Y.; Evans J. E.; Rock K.L. Molecular Identification of A Danger Signal That Alerts The Immune System to Dying Cells. Nature 2003, 425(6957), 516-521.
35. Grases F.; Villacampa A. I.; Costa-Bauzá A.; Söhnel O. Uric Acid Calculi: Types, Etiology and Mechanism of Formation. Clin. Chim. Acta 2000, 302(1-2), 89-104.
36. Grases F.; Villacampa A. I.; Costa-Bauzá A.; Söhnel O. Uric Acid Calculi. Scanning Microscopy 1999, 13(2-3), 223-234.
37. Sours R. E.; Fink D. A.; Swif t J. A. Dyeing Uric Acid Crystals with Methylene Blue. J. Am. Chem. Soc. 2002, 124(29), 8630-8636.
38. Zellelow A. Z.; Kim K. H.; Sours R. E.; Swift J. A. Solid-state Dehydration of Uric Acid Dihydrate. Cryst. Growth Des. 2010, 10(1), 418-425.
39. Wilson E. V.; Bushiri M. J.; Vaidyan V. K. Analytical Characterization, Thermal and FTIR Studies of Urinary Calculi. J. Optoelectron. Biomed. Mater. 2010, 2(2), 85-90.
40. Shirley R. Uric Acid Dihydrate: Crystallography and Identification. Science 1966, 152(3728), 1512-1513.
41. Anderson N. G. Practical Process Research & Development; Academic Press: New York, 2000; pp. 81–111.
42. Kociba K. J.; Gallagher P. K. A Study of Calcium Oxalate Monohydrate Using Dynamic Differential Scanning Calorimetry and Other Thermoanalytical Techniques. Thermochim. Acta 1996, 282/283(1), 277-296.
43. Jung T.; Kim W. S.; Choi C. K. Crystal Structure and Morphology Control of Calcium Oxalate Using Biopolymeric Additives in Crystallization. J. Cryst. Growth 2005, 279(1-2), 154-162.
44. Robertson W. G.; Jones J. S.; Heaton M. A.; Stevenson A. E.; Markwell P. J. Predicting the Crystallization Potential of Urine from Cats and Dogs with Respect to Calcium Oxalate and Magnesium Ammonium Phosphate. J. Nutr. 2002, 132(6), 1637S-1641S.
45. Grases F.; Millan A.; Conte A. Production of Calcium Oxalate Monohydrate, Dihydrate or Trihydrate. Urol. Res. 1990, 18(1), 17-20.
46. Doherty W. O. S.; Crees O. L.; Senogles E. The Preparation of Calcium Oxalate Dihydrate Crystals. Cryst. Res.Techno. 1994, 29(4), 517-524.
47. Lee T.; Lin M. S. Sublimation Point Depression of Tris(8-hydroxyquinoline) aluminum(III) (Alq3) by Crystal Engineering. J. Cryst. Growth 2007, 7(9), 1803-1810.
48. Berkovitch-Yellin Z.; Mil J. V.; Addadi L.; Idelson M.; Lahav M.; Leiserowitz L. Crystal Morphology Engineering by "Tailor-made" Inhibitors; A New Probe to Fine Intermolecular Interactions. J. Am. Chem. Soc. 1985, 107(11), 3111-3122.
49. Laskowski D. E. Chemical Microscopy of Urinary Calculi. Anal. Chem. 1965, 37(11), 1399–1404.
50. Schubert G.; Reck G.; Jancke H.; Kraus W.; Patzelt C. Uric Acid Monohydrate- A New Urinary Calculus Phase. Urol. Res. 2005, 33(3), 231-238.
51. Bunyan J. M. E.; Shankland N.; Sheen D. B. Solvent Effect on The Morphology of Ibuprofen. Particle Design via Crystallization AIChE Symp. Series 1991, 87(284), 44-57.
52. Kaloustian J.; Pauli A. M.; Pieroni G.; Portugal H. The Use of Thermal Analysis in Determination of Some Urinary Calculi of Calcium Oxalate. J. Therm. Anal. Calorim. 2002, 70(3), 959-973.
53. Valarmathi D.; Abraham L.; Gunasekaran S. Growth of Calcium Oxalate Monohydrate Crystal by Gel Method and Its Spectroscopic Analysis. Indian J. Pure Appl. Phys. 2010, 48(1), 36-38.
54. Girija E. K.; Latha S. C.; Kalkura S. N.; Subramanian C.; Ramasamy P. Crystallization and Microhardness of Calcium Oxalate Monohydrate. Mater. Chem. Phys. 1998, 52(3), 253-257.
55. Zhang Y.; Tao J.; Feng N.; Han X. Crystal Growth of Calcium Oxalate Induced by The Extracts of Semen Plantaginis and Folium Pyrrosiae. Cryst. Res. Technol 2008, 43(9), 931-934.
|